Korean J Med.
2015 Jun;88(6):701-705. 10.3904/kjm.2015.88.6.701.
Recurrence of Tuberculosis after Resuming a TNF-Inhibitor in a Patient with Crohn's Disease
- Affiliations
-
- 1Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. heathcliff6800@hanmail.net
- KMID: 2269085
- DOI: http://doi.org/10.3904/kjm.2015.88.6.701
Abstract
- The use of tumor necrosis factor inhibitors (TNFi) increases a patient's risk of developing tuberculosis (TB). There is no consensus on whether restarting a TNFi after treating an active TB infection caused by previous TNFi exposure is safe. We report the first case of TB recurrence after recommencing a TNFi in a 37-year-old woman with a history of active TB infection caused by previous TNFi treatment.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
- Tuberculous Meningitis in a Patient with Crohn's Disease, Which was Treated with Infliximab
- A Case of Multiple Tuberculosis Associated with Infliximab Therapy in Crohn's Disease
- Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
- Guidelines for Prevention of Tuberculosis in Patients with Rheumatoid Arthritis Treated with TNF-alpha Blockers
